
Please try another search
NeoGenomics (NEO) reported Q3 EPS of ($0.14), $0.06 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $128.78 million versus the consensus estimate of $122.41 million.
Investing.com - NeoGenomics reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations. NeoGenomics announced earnings per share of $-0.14 on...
DevvStream (DESG-NEO) is set to become the first big technology solution to the carbon credit supply problem. They just listed TODAY– They have unique expertise, a unique business model...
By Sam Boughedda A Needham & Company analyst downgraded shares of NeoGenomics (NASDAQ:NEO) to Hold from Buy, removing the previous $16 per share price target on the stock. The analyst said in a...
Pre-Open Stock Movers Signify Health, Inc. (SGFY) 41% HIGHER; Amazon, UnitedHealth among bidders for the company, the WSJ reported. Previously CVS showed interest. AMC Entertainment Holdings, Inc....
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review